This resource is primarily used for the identification and definition of a medication, including ingredients, for the purposes of prescribing, dispensing, and administering a medication as well as for making statements about medication use.

A reference to a set of rules that were followed when the resource was constructed, and which must be understood when processing the content. Often, this is a reference to an implementation guide that defines the special rules along with other profiles etc.

Asserting this rule set restricts the content to be only understood by a limited set of trading partners. This inherently limits the usefulness of the data in the long term. However, the existing health eco-system is highly fractured, and not yet ready to define, collect, and exchange data in a generally computable sense. Wherever possible, implementers and/or specification writers should avoid using this element. Often, when used, the URL is a reference to an implementation guide that defines these special rules as part of its narrative along with other profiles, value sets, etc.

These resources do not have an independent existence apart from the resource that contains them - they cannot be identified independently, nor can they have their own independent transaction scope. This is allowed to be a Parameters resource if and only if it is referenced by a resource that provides context/meaning.

This should never be done when the content can be identified properly, as once identification is lost, it is extremely difficult (and context dependent) to restore it again. Contained resources may have profiles and tags in their meta elements, but SHALL NOT have security labels.

May be used to represent additional information that is not part of the basic definition of the resource and that modifies the understanding of the element that contains it and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer is allowed to define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Nombre comercial del medicamento tal como lo reportó el notificador, junto con su identificación codificada (si está disponible) para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Depending on the context of use, the code that was actually selected by the user (prescriber, dispenser, etc.) will have the coding.userSelected set to true. As described in the coding datatype: "A coding may be marked as a "userSelected" if a user selected the particular coded value in a user interface (e.g. the user selects an item in a pick-list). If a user selected coding exists, it is the preferred choice for performing translations etc. Other codes can only be literal translations to alternative code systems, or codes at a lower level of granularity (e.g. a generic code for a vendor-specific primary one).

A coded concept that defines the type of a medication.

Código del medicamento según la clasificación WHODrug, que puede corresponder al principio activo o al producto terminado, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Codes may be defined very casually in enumerations, or code lists, up to very formal definitions such as SNOMED CT - see the HL7 v3 Core Principles for more information. Ordering of codings is undefined and SHALL NOT be used to infer meaning. Generally, at most only one of the coding values will be labeled as UserSelected = true.

Allows for alternative encodings within a code system, and translations to other code systems.

URI que identifica el sistema de codificación WHODrug utilizado para codificar el medicamento en las notificaciones FACEDRA.

The URI may be an OID (urn:oid:...) or a UUID (urn:uuid:...). OIDs and UUIDs SHALL be references to the HL7 OID registry. Otherwise, the URI should come from HL7's list of FHIR defined special URIs or it should be an absolute reference to some definition that establishes the system clearly and unambiguously.

Need to be unambiguous about the source of the definition of the symbol.

Código del medicamento según la clasificación WHODrug, que puede corresponder al principio activo o al producto terminado, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Need to refer to a particular code in the system.

Nombre del medicamento según la clasificación WHODrug, que puede corresponder al principio activo o al producto terminado, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Need to be able to carry a human-readable meaning of the code for readers that do not know the system.

Nombre del medicamento tal como lo reportó el notificador, sin normalizar ni codificar, para preservar la información original proporcionada en la notificación FACEDRA.

Very often the text is the same as a displayName of one of the codings.

The codes from the terminologies do not always capture the correct meaning with all the nuances of the human using them, or sometimes there is no appropriate code at all. In these cases, the text is used to capture the full meaning of the source.

Estado del medicamento reportado en las notificaciones FACEDRA, que indica si el medicamento está actualmente en uso (active) o si ha sido retirado del mercado o descontinuado (inactive) para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

This status is intended to identify if the medication in a local system is in active use within a drug database or inventory. For example, a pharmacy system may create a new drug file record for a compounded product "ABC Hospital Special Cream" with an active status. At some point in the future, it may be determined that the drug record was created with an error and the status is changed to "entered in error". This status is not intended to specify if a medication is part of a particular formulary. It is possible that the drug record may be referenced by multiple formularies or catalogues and each of those entries would have a separate status.

A coded concept defining if the medication is in active use.

Laboratorio titular del registro sanitario del medicamento reportado en las notificaciones FACEDRA, para facilitar la identificación y seguimiento de los responsables de la autorización de los medicamentos en las notificaciones FACEDRA.

Forma farmacéutica del medicamento reportado en las notificaciones FACEDRA, que describe la presentación física del medicamento (por ejemplo, tableta, cápsula, inyectable, etc.) para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

When Medication is referenced from MedicationRequest, this is the ordered form. When Medication is referenced within MedicationDispense, this is the dispensed form. When Medication is referenced within MedicationAdministration, this is administered form.

A coded concept defining the form of a medication.

Código que representa la forma farmacéutica del medicamento reportado en las notificaciones FACEDRA, utilizando un sistema de codificación estándar para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Codes may be defined very casually in enumerations, or code lists, up to very formal definitions such as SNOMED CT - see the HL7 v3 Core Principles for more information. Ordering of codings is undefined and SHALL NOT be used to infer meaning. Generally, at most only one of the coding values will be labeled as UserSelected = true.

Allows for alternative encodings within a code system, and translations to other code systems.

The identification of the code system that defines the meaning of the symbol in the code.

The URI may be an OID (urn:oid:...) or a UUID (urn:uuid:...). OIDs and UUIDs SHALL be references to the HL7 OID registry. Otherwise, the URI should come from HL7's list of FHIR defined special URIs or it should be an absolute reference to some definition that establishes the system clearly and unambiguously.

Need to be unambiguous about the source of the definition of the symbol.

Código que representa la forma farmacéutica del medicamento reportado en las notificaciones FACEDRA, utilizando un sistema de codificación estándar para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Need to refer to a particular code in the system.

Nombre de la forma farmacéutica del medicamento reportado en las notificaciones FACEDRA, utilizando un sistema de codificación estándar para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Need to be able to carry a human-readable meaning of the code for readers that do not know the system.

Información detallada sobre el o los principios activos presentes en el medicamento reportado en las notificaciones FACEDRA, incluyendo su identificación codificada (si está disponible), concentración, forma farmacéutica, lote, fecha de caducidad y titular de venta, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

The ingredients need not be a complete list. If an ingredient is not specified, this does not indicate whether an ingredient is present or absent. If an ingredient is specified it does not mean that all ingredients are specified. It is possible to specify both inactive and active ingredients.

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Identificación codificada del principio activo presente en el medicamento reportado en las notificaciones FACEDRA, utilizando la clasificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

The ingredient may reference a substance (for example, amoxicillin) or another medication (for example in the case of a compounded product, Glaxal Base).

Specifies how many (or how much) of the items there are in this Medication. For example, 250 mg per tablet. This is expressed as a ratio where the numerator is 250mg and the denominator is 1 tablet but can also be expressed a quantity when the denominator is assumed to be 1 tablet.

A coded concpet defining the strength of an ingredient.

Concentración del principio activo presente en el medicamento reportado en las notificaciones FACEDRA, expresada como una proporción (numerador/denominador) para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Valor numérico del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA.

Valor numérico del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA.

The implicit precision in the value should always be honored. Monetary values have their own rules for handling precision (refer to standard accounting text books).

Precision is handled implicitly in almost all cases of measurement.

How the value should be understood and represented - whether the actual value is greater or less than the stated value due to measurement issues; e.g. if the comparator is "<" , then the real value is < stated value.

How the Quantity should be understood and represented.

Need a framework for handling measures where the value is <5ug/L or >400mg/L due to the limitations of measuring methodology.

Unidad de medida del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

There are many representations for units of measure and in many contexts, particular representations are fixed and required. I.e. mcg for micrograms.

URI que identifica el sistema de codificación de unidades de medida utilizado para codificar la unidad del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Need to know the system that defines the coded form of the unit.

Código de la unidad de medida del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

The preferred system is UCUM, but SNOMED CT can also be used (for customary units) or ISO 4217 for currency. The context of use may additionally require a code from a particular system.

Need a computable form of the unit that is fixed across all forms. UCUM provides this for quantities, but SNOMED CT provides many units of interest.

Valor numérico del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA.

Valor numérico del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA.

The implicit precision in the value should always be honored. Monetary values have their own rules for handling precision (refer to standard accounting text books).

Precision is handled implicitly in almost all cases of measurement.

Not allowed to be used in this context

How the Quantity should be understood and represented.

Need a framework for handling measures where the value is <5ug/L or >400mg/L due to the limitations of measuring methodology.

Unidad de medida del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

There are many representations for units of measure and in many contexts, particular representations are fixed and required. I.e. mcg for micrograms.

URI que identifica el sistema de codificación de unidades de medida utilizado para codificar la unidad del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Need to know the system that defines the coded form of the unit.

Código de la unidad de medida del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

The preferred system is UCUM, but SNOMED CT can also be used (for customary units) or ISO 4217 for currency. The context of use may additionally require a code from a particular system.

Need a computable form of the unit that is fixed across all forms. UCUM provides this for quantities, but SNOMED CT provides many units of interest.

Información sobre el lote y la fecha de caducidad del medicamento reportado en las notificaciones FACEDRA, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA, así como para apoyar la identificación de posibles problemas relacionados con lotes específicos de medicamentos en las notificaciones FACEDRA.

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Número de lote del medicamento reportado en las notificaciones FACEDRA, impreso en el empaque, para facilitar la identificación y seguimiento de lotes específicos en las notificaciones FACEDRA.

Fecha de caducidad del medicamento reportado en las notificaciones FACEDRA, en formato MM/AAAA, para facilitar la identificación y seguimiento de la validez de los medicamentos en las notificaciones FACEDRA.

Nombre comercial del medicamento tal como lo reportó el notificador, junto con su identificación codificada (si está disponible) para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Código del medicamento según la clasificación WHODrug, que puede corresponder al principio activo o al producto terminado, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

URI que identifica el sistema de codificación WHODrug utilizado para codificar el medicamento en las notificaciones FACEDRA.

Código del medicamento según la clasificación WHODrug, que puede corresponder al principio activo o al producto terminado, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Nombre del medicamento según la clasificación WHODrug, que puede corresponder al principio activo o al producto terminado, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Nombre del medicamento tal como lo reportó el notificador, sin normalizar ni codificar, para preservar la información original proporcionada en la notificación FACEDRA.

Estado del medicamento reportado en las notificaciones FACEDRA, que indica si el medicamento está actualmente en uso (active) o si ha sido retirado del mercado o descontinuado (inactive) para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Laboratorio titular del registro sanitario del medicamento reportado en las notificaciones FACEDRA, para facilitar la identificación y seguimiento de los responsables de la autorización de los medicamentos en las notificaciones FACEDRA.

Forma farmacéutica del medicamento reportado en las notificaciones FACEDRA, que describe la presentación física del medicamento (por ejemplo, tableta, cápsula, inyectable, etc.) para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Código que representa la forma farmacéutica del medicamento reportado en las notificaciones FACEDRA, utilizando un sistema de codificación estándar para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Código que representa la forma farmacéutica del medicamento reportado en las notificaciones FACEDRA, utilizando un sistema de codificación estándar para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Nombre de la forma farmacéutica del medicamento reportado en las notificaciones FACEDRA, utilizando un sistema de codificación estándar para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Información detallada sobre el o los principios activos presentes en el medicamento reportado en las notificaciones FACEDRA, incluyendo su identificación codificada (si está disponible), concentración, forma farmacéutica, lote, fecha de caducidad y titular de venta, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Identificación codificada del principio activo presente en el medicamento reportado en las notificaciones FACEDRA, utilizando la clasificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

URI que identifica el sistema de codificación WHODrug utilizado para codificar el principio activo en las notificaciones FACEDRA.

Nombre del principio activo en texto libre, tal como lo reportó el notificador en las notificaciones FACEDRA, para preservar la información original proporcionada y facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Concentración del principio activo presente en el medicamento reportado en las notificaciones FACEDRA, expresada como una proporción (numerador/denominador) para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Valor numérico del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA.

Valor numérico del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA.

Unidad de medida del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

URI que identifica el sistema de codificación de unidades de medida utilizado para codificar la unidad del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Código de la unidad de medida del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Valor numérico del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA.

Valor numérico del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA.

Unidad de medida del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

URI que identifica el sistema de codificación de unidades de medida utilizado para codificar la unidad del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Código de la unidad de medida del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Información sobre el lote y la fecha de caducidad del medicamento reportado en las notificaciones FACEDRA, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA, así como para apoyar la identificación de posibles problemas relacionados con lotes específicos de medicamentos en las notificaciones FACEDRA.

Número de lote del medicamento reportado en las notificaciones FACEDRA, impreso en el empaque, para facilitar la identificación y seguimiento de lotes específicos en las notificaciones FACEDRA.

Fecha de caducidad del medicamento reportado en las notificaciones FACEDRA, en formato MM/AAAA, para facilitar la identificación y seguimiento de la validez de los medicamentos en las notificaciones FACEDRA.

This resource is primarily used for the identification and definition of a medication, including ingredients, for the purposes of prescribing, dispensing, and administering a medication as well as for making statements about medication use.

The logical id of the resource, as used in the URL for the resource. Once assigned, this value never changes.

Within the context of the FHIR RESTful interactions, the resource has an id except for cases like the create and conditional update. Otherwise, the use of the resouce id depends on the given use case.

The metadata about the resource. This is content that is maintained by the infrastructure. Changes to the content might not always be associated with version changes to the resource.

A reference to a set of rules that were followed when the resource was constructed, and which must be understood when processing the content. Often, this is a reference to an implementation guide that defines the special rules along with other profiles etc.

Asserting this rule set restricts the content to be only understood by a limited set of trading partners. This inherently limits the usefulness of the data in the long term. However, the existing health eco-system is highly fractured, and not yet ready to define, collect, and exchange data in a generally computable sense. Wherever possible, implementers and/or specification writers should avoid using this element. Often, when used, the URL is a reference to an implementation guide that defines these special rules as part of its narrative along with other profiles, value sets, etc.

The base language in which the resource is written.

Language is provided to support indexing and accessibility (typically, services such as text to speech use the language tag). The html language tag in the narrative applies to the narrative. The language tag on the resource may be used to specify the language of other presentations generated from the data in the resource. Not all the content has to be in the base language. The Resource.language should not be assumed to apply to the narrative automatically. If a language is specified, it should it also be specified on the div element in the html (see rules in HTML5 for information about the relationship between xml:lang and the html lang attribute).

IETF language tag for a human language

A human-readable narrative that contains a summary of the resource and can be used to represent the content of the resource to a human. The narrative need not encode all the structured data, but is required to contain sufficient detail to make it "clinically safe" for a human to just read the narrative. Resource definitions may define what content should be represented in the narrative to ensure clinical safety.

Contained resources do not have a narrative. Resources that are not contained SHOULD have a narrative. In some cases, a resource may only have text with little or no additional discrete data (as long as all minOccurs=1 elements are satisfied). This may be necessary for data from legacy systems where information is captured as a "text blob" or where text is additionally entered raw or narrated and encoded information is added later.

These resources do not have an independent existence apart from the resource that contains them - they cannot be identified independently, nor can they have their own independent transaction scope. This is allowed to be a Parameters resource if and only if it is referenced by a resource that provides context/meaning.

This should never be done when the content can be identified properly, as once identification is lost, it is extremely difficult (and context dependent) to restore it again. Contained resources may have profiles and tags in their meta elements, but SHALL NOT have security labels.

May be used to represent additional information that is not part of the basic definition of the resource. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

May be used to represent additional information that is not part of the basic definition of the resource and that modifies the understanding of the element that contains it and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer is allowed to define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Business identifier for this medication.

The serial number could be included as an identifier.

Nombre comercial del medicamento tal como lo reportó el notificador, junto con su identificación codificada (si está disponible) para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Depending on the context of use, the code that was actually selected by the user (prescriber, dispenser, etc.) will have the coding.userSelected set to true. As described in the coding datatype: "A coding may be marked as a "userSelected" if a user selected the particular coded value in a user interface (e.g. the user selects an item in a pick-list). If a user selected coding exists, it is the preferred choice for performing translations etc. Other codes can only be literal translations to alternative code systems, or codes at a lower level of granularity (e.g. a generic code for a vendor-specific primary one).

A coded concept that defines the type of a medication.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Código del medicamento según la clasificación WHODrug, que puede corresponder al principio activo o al producto terminado, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Codes may be defined very casually in enumerations, or code lists, up to very formal definitions such as SNOMED CT - see the HL7 v3 Core Principles for more information. Ordering of codings is undefined and SHALL NOT be used to infer meaning. Generally, at most only one of the coding values will be labeled as UserSelected = true.

Allows for alternative encodings within a code system, and translations to other code systems.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

URI que identifica el sistema de codificación WHODrug utilizado para codificar el medicamento en las notificaciones FACEDRA.

The URI may be an OID (urn:oid:...) or a UUID (urn:uuid:...). OIDs and UUIDs SHALL be references to the HL7 OID registry. Otherwise, the URI should come from HL7's list of FHIR defined special URIs or it should be an absolute reference to some definition that establishes the system clearly and unambiguously.

Need to be unambiguous about the source of the definition of the symbol.

The version of the code system which was used when choosing this code. Note that a well-maintained code system does not need the version reported, because the meaning of codes is consistent across versions. However this cannot consistently be assured, and when the meaning is not guaranteed to be consistent, the version SHOULD be exchanged.

Where the terminology does not clearly define what string should be used to identify code system versions, the recommendation is to use the date (expressed in FHIR date format) on which that version was officially published as the version date.

Código del medicamento según la clasificación WHODrug, que puede corresponder al principio activo o al producto terminado, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Need to refer to a particular code in the system.

Nombre del medicamento según la clasificación WHODrug, que puede corresponder al principio activo o al producto terminado, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Need to be able to carry a human-readable meaning of the code for readers that do not know the system.

Indicates that this coding was chosen by a user directly - e.g. off a pick list of available items (codes or displays).

Amongst a set of alternatives, a directly chosen code is the most appropriate starting point for new translations. There is some ambiguity about what exactly 'directly chosen' implies, and trading partner agreement may be needed to clarify the use of this element and its consequences more completely.

This has been identified as a clinical safety criterium - that this exact system/code pair was chosen explicitly, rather than inferred by the system based on some rules or language processing.

Nombre del medicamento tal como lo reportó el notificador, sin normalizar ni codificar, para preservar la información original proporcionada en la notificación FACEDRA.

Very often the text is the same as a displayName of one of the codings.

The codes from the terminologies do not always capture the correct meaning with all the nuances of the human using them, or sometimes there is no appropriate code at all. In these cases, the text is used to capture the full meaning of the source.

Estado del medicamento reportado en las notificaciones FACEDRA, que indica si el medicamento está actualmente en uso (active) o si ha sido retirado del mercado o descontinuado (inactive) para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

This status is intended to identify if the medication in a local system is in active use within a drug database or inventory. For example, a pharmacy system may create a new drug file record for a compounded product "ABC Hospital Special Cream" with an active status. At some point in the future, it may be determined that the drug record was created with an error and the status is changed to "entered in error". This status is not intended to specify if a medication is part of a particular formulary. It is possible that the drug record may be referenced by multiple formularies or catalogues and each of those entries would have a separate status.

A coded concept defining if the medication is in active use.

Laboratorio titular del registro sanitario del medicamento reportado en las notificaciones FACEDRA, para facilitar la identificación y seguimiento de los responsables de la autorización de los medicamentos en las notificaciones FACEDRA.

Forma farmacéutica del medicamento reportado en las notificaciones FACEDRA, que describe la presentación física del medicamento (por ejemplo, tableta, cápsula, inyectable, etc.) para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

When Medication is referenced from MedicationRequest, this is the ordered form. When Medication is referenced within MedicationDispense, this is the dispensed form. When Medication is referenced within MedicationAdministration, this is administered form.

A coded concept defining the form of a medication.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Código que representa la forma farmacéutica del medicamento reportado en las notificaciones FACEDRA, utilizando un sistema de codificación estándar para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Codes may be defined very casually in enumerations, or code lists, up to very formal definitions such as SNOMED CT - see the HL7 v3 Core Principles for more information. Ordering of codings is undefined and SHALL NOT be used to infer meaning. Generally, at most only one of the coding values will be labeled as UserSelected = true.

Allows for alternative encodings within a code system, and translations to other code systems.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

The identification of the code system that defines the meaning of the symbol in the code.

The URI may be an OID (urn:oid:...) or a UUID (urn:uuid:...). OIDs and UUIDs SHALL be references to the HL7 OID registry. Otherwise, the URI should come from HL7's list of FHIR defined special URIs or it should be an absolute reference to some definition that establishes the system clearly and unambiguously.

Need to be unambiguous about the source of the definition of the symbol.

The version of the code system which was used when choosing this code. Note that a well-maintained code system does not need the version reported, because the meaning of codes is consistent across versions. However this cannot consistently be assured, and when the meaning is not guaranteed to be consistent, the version SHOULD be exchanged.

Where the terminology does not clearly define what string should be used to identify code system versions, the recommendation is to use the date (expressed in FHIR date format) on which that version was officially published as the version date.

Código que representa la forma farmacéutica del medicamento reportado en las notificaciones FACEDRA, utilizando un sistema de codificación estándar para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Need to refer to a particular code in the system.

Nombre de la forma farmacéutica del medicamento reportado en las notificaciones FACEDRA, utilizando un sistema de codificación estándar para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Need to be able to carry a human-readable meaning of the code for readers that do not know the system.

Indicates that this coding was chosen by a user directly - e.g. off a pick list of available items (codes or displays).

Amongst a set of alternatives, a directly chosen code is the most appropriate starting point for new translations. There is some ambiguity about what exactly 'directly chosen' implies, and trading partner agreement may be needed to clarify the use of this element and its consequences more completely.

This has been identified as a clinical safety criterium - that this exact system/code pair was chosen explicitly, rather than inferred by the system based on some rules or language processing.

A human language representation of the concept as seen/selected/uttered by the user who entered the data and/or which represents the intended meaning of the user.

Very often the text is the same as a displayName of one of the codings.

The codes from the terminologies do not always capture the correct meaning with all the nuances of the human using them, or sometimes there is no appropriate code at all. In these cases, the text is used to capture the full meaning of the source.

When the specified product code does not infer a package size, this is the specific amount of drug in the product. For example, when specifying a product that has the same strength (For example, Insulin glargine 100 unit per mL solution for injection), this attribute provides additional clarification of the package amount (For example, 3 mL, 10mL, etc.).

Información detallada sobre el o los principios activos presentes en el medicamento reportado en las notificaciones FACEDRA, incluyendo su identificación codificada (si está disponible), concentración, forma farmacéutica, lote, fecha de caducidad y titular de venta, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

The ingredients need not be a complete list. If an ingredient is not specified, this does not indicate whether an ingredient is present or absent. If an ingredient is specified it does not mean that all ingredients are specified. It is possible to specify both inactive and active ingredients.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Identificación codificada del principio activo presente en el medicamento reportado en las notificaciones FACEDRA, utilizando la clasificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

The ingredient may reference a substance (for example, amoxicillin) or another medication (for example in the case of a compounded product, Glaxal Base).

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

A reference to a concept - e.g. the information is identified by its general class to the degree of precision found in the terminology.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

A reference to a code defined by a terminology system.

Codes may be defined very casually in enumerations, or code lists, up to very formal definitions such as SNOMED CT - see the HL7 v3 Core Principles for more information. Ordering of codings is undefined and SHALL NOT be used to infer meaning. Generally, at most only one of the coding values will be labeled as UserSelected = true.

Allows for alternative encodings within a code system, and translations to other code systems.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

URI que identifica el sistema de codificación WHODrug utilizado para codificar el principio activo en las notificaciones FACEDRA.

The URI may be an OID (urn:oid:...) or a UUID (urn:uuid:...). OIDs and UUIDs SHALL be references to the HL7 OID registry. Otherwise, the URI should come from HL7's list of FHIR defined special URIs or it should be an absolute reference to some definition that establishes the system clearly and unambiguously.

Need to be unambiguous about the source of the definition of the symbol.

The version of the code system which was used when choosing this code. Note that a well-maintained code system does not need the version reported, because the meaning of codes is consistent across versions. However this cannot consistently be assured, and when the meaning is not guaranteed to be consistent, the version SHOULD be exchanged.

Where the terminology does not clearly define what string should be used to identify code system versions, the recommendation is to use the date (expressed in FHIR date format) on which that version was officially published as the version date.

A symbol in syntax defined by the system. The symbol may be a predefined code or an expression in a syntax defined by the coding system (e.g. post-coordination).

Need to refer to a particular code in the system.

A representation of the meaning of the code in the system, following the rules of the system.

Need to be able to carry a human-readable meaning of the code for readers that do not know the system.

Indicates that this coding was chosen by a user directly - e.g. off a pick list of available items (codes or displays).

Amongst a set of alternatives, a directly chosen code is the most appropriate starting point for new translations. There is some ambiguity about what exactly 'directly chosen' implies, and trading partner agreement may be needed to clarify the use of this element and its consequences more completely.

This has been identified as a clinical safety criterium - that this exact system/code pair was chosen explicitly, rather than inferred by the system based on some rules or language processing.

Nombre del principio activo en texto libre, tal como lo reportó el notificador en las notificaciones FACEDRA, para preservar la información original proporcionada y facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Very often the text is the same as a displayName of one of the codings.

The codes from the terminologies do not always capture the correct meaning with all the nuances of the human using them, or sometimes there is no appropriate code at all. In these cases, the text is used to capture the full meaning of the source.

A reference to a resource the provides exact details about the information being referenced.

Indication of whether this ingredient affects the therapeutic action of the drug.

True indicates that the ingredient affects the therapeutic action of the drug (i.e. active). False indicates that the ingredient does not affect the therapeutic action of the drug (i.e. inactive).

Specifies how many (or how much) of the items there are in this Medication. For example, 250 mg per tablet. This is expressed as a ratio where the numerator is 250mg and the denominator is 1 tablet but can also be expressed a quantity when the denominator is assumed to be 1 tablet.

A coded concpet defining the strength of an ingredient.

Concentración del principio activo presente en el medicamento reportado en las notificaciones FACEDRA, expresada como una proporción (numerador/denominador) para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Valor numérico del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Valor numérico del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA.

The implicit precision in the value should always be honored. Monetary values have their own rules for handling precision (refer to standard accounting text books).

Precision is handled implicitly in almost all cases of measurement.

How the value should be understood and represented - whether the actual value is greater or less than the stated value due to measurement issues; e.g. if the comparator is "<" , then the real value is < stated value.

How the Quantity should be understood and represented.

Need a framework for handling measures where the value is <5ug/L or >400mg/L due to the limitations of measuring methodology.

Unidad de medida del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

There are many representations for units of measure and in many contexts, particular representations are fixed and required. I.e. mcg for micrograms.

URI que identifica el sistema de codificación de unidades de medida utilizado para codificar la unidad del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Need to know the system that defines the coded form of the unit.

Código de la unidad de medida del numerador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

The preferred system is UCUM, but SNOMED CT can also be used (for customary units) or ISO 4217 for currency. The context of use may additionally require a code from a particular system.

Need a computable form of the unit that is fixed across all forms. UCUM provides this for quantities, but SNOMED CT provides many units of interest.

Valor numérico del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Valor numérico del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA.

The implicit precision in the value should always be honored. Monetary values have their own rules for handling precision (refer to standard accounting text books).

Precision is handled implicitly in almost all cases of measurement.

Not allowed to be used in this context

How the Quantity should be understood and represented.

Need a framework for handling measures where the value is <5ug/L or >400mg/L due to the limitations of measuring methodology.

Unidad de medida del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

There are many representations for units of measure and in many contexts, particular representations are fixed and required. I.e. mcg for micrograms.

URI que identifica el sistema de codificación de unidades de medida utilizado para codificar la unidad del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

Need to know the system that defines the coded form of the unit.

Código de la unidad de medida del denominador en la proporción que representa la concentración del principio activo en el medicamento reportado en las notificaciones FACEDRA, utilizando las unidades de medida estándar definidas en el sistema de codificación WHODrug para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA.

The preferred system is UCUM, but SNOMED CT can also be used (for customary units) or ISO 4217 for currency. The context of use may additionally require a code from a particular system.

Need a computable form of the unit that is fixed across all forms. UCUM provides this for quantities, but SNOMED CT provides many units of interest.

Información sobre el lote y la fecha de caducidad del medicamento reportado en las notificaciones FACEDRA, para facilitar la normalización y análisis de los datos de medicamentos en las notificaciones FACEDRA, así como para apoyar la identificación de posibles problemas relacionados con lotes específicos de medicamentos en las notificaciones FACEDRA.

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Número de lote del medicamento reportado en las notificaciones FACEDRA, impreso en el empaque, para facilitar la identificación y seguimiento de lotes específicos en las notificaciones FACEDRA.

Fecha de caducidad del medicamento reportado en las notificaciones FACEDRA, en formato MM/AAAA, para facilitar la identificación y seguimiento de la validez de los medicamentos en las notificaciones FACEDRA.

A reference to a knowledge resource that provides more information about this medication.